CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Sees Significant Increase in Short Interest

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the recipient of a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 160,001 shares, an increase of 16,000,000.0% from the October 15th total of 1 shares. Based on an average trading volume of 31,920,948 shares, the short-interest ratio is presently 0.0 days.

CNBX Pharmaceuticals Stock Performance

CNBX Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $0.00.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals, Inc. is a biotechnology company focused on developing cannabinoid-based pharmaceutical products and treatments. Its research has centered on the potential use of medical cannabis compounds in oncology and other therapeutic applications. The company has worked on technologies designed to evaluate how individual cancer cells respond to different cannabinoid formulations. Its development activities have included cannabinoid-based oral products and personalized-treatment approaches intended to help identify potentially effective therapies for specific patients.